Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Change in Account Payables (2024 - 2025)

Beta Bionics (BBNX) has disclosed Change in Account Payables for 2 consecutive years, with $527000.0 as the latest value for Q4 2025.

  • Quarterly Change in Account Payables rose 963.93% to $527000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2025, up 38.48% year-over-year, with the annual reading at $2.1 million for FY2025, 38.48% up from the prior year.
  • Change in Account Payables hit $527000.0 in Q4 2025 for Beta Bionics, down from $1.1 million in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $1.1 million in Q3 2025 to a low of -$97000.0 in Q1 2025.